(Q38231113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Manfredi Rizzo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Angelo Maria Patti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Niki Katsiki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Khalid Al-Rasadi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

18 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

416-421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

Drug discovery and natural products: end of an era or an endless frontier?

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Natural products in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Natural products as leads to potential drugs: an old process or the new hope for drug discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Developing a drug-like natural product library

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Drug discovery from natural sources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Breast phyllodes tumor: a review of literature and a single center retrospective series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

History of polio vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

AfroDb: a select highly potent and diverse natural product library from African medicinal plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Further evidence for the anti-inflammatory activity of oleocanthal: inhibition of MIP-1α and IL-6 in J774 macrophages and in ATDC5 chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Oleocanthal in olive oil: between myth and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Impact of probiotics on risk factors for cardiovascular diseases. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Gut microbiome and metabolic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Chitosan modification and pharmaceutical/biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Multi-functional roles of chitosan as a potential protective agent against obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Dietary supplementation with chitosan derived from mushrooms changes adipocytokine profile in diet-induced obese mice, a phenomenon linked to its lipid-lowering action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Effect of chitosan, O-carboxymethyl chitosan, and N-[(2-hydroxy-3-N,N-dimethylhexadecyl ammonium)propyl] chitosan chloride on overweight and insulin resistance in a murine diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Chitosan ameliorates the severity of steatohepatitis induced by high fat diet in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Metabolic syndrome and non-cardiac vascular diseases: an update from human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Improvement of HDL- and LDL-cholesterol levels in diabetic subjects by feeding bread containing chitosan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Atherogenic versus non-atherogenic lipoprotein profiles in healthy individuals. is there a need to change our approach to diagnosing dyslipidemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Chitooligosaccharides decreases plasma lipid levels in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Injectable chitosan-based scaffolds in regenerative medicine and their clinical translatability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Effect of green tea extract microencapsulation on hypertriglyceridemia and cardiovascular tissues in high fructose-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Key points for maximum effectiveness and safety for cholesterol-lowering properties of plant sterols and use in the treatment of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Chitin-glucan fiber effects on oxidized low-density lipoprotein: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

Multiple dietary supplements do not affect metabolic and cardio-vascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0003319714542999

21 January 2018

Identifiers

DOI

10.1177/0003319714542999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25037700%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference